Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 2/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 4/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5932957 | 0.84 | TDP1 (0.39) | TRPA1ATMCYP2A6CYP1A2CYP3A4 | |
| SCHEMBL29364976 | 0.83 | SMN1; SMN2 (0.47) | TRPA1ATMCYP2A6CYP1A2CYP3A4 | |
| SCHEMBL11696808 | 0.83 | SMN1; SMN2 (0.47) | TRPA1ATMCYP2A6CYP1A2CYP3A4 | |
| SCHEMBL10106300 | 0.83 | SMN1; SMN2 (0.47) | TRPA1ATMCYP2A6CYP1A2CYP3A4 | |
| SCHEMBL4394449 | 0.81 | TRPA1 (0.44) | TRPA1ATMCYP2A6CYP1A2CYP3A4 | |
| SCHEMBL14669788 | 0.79 | TRPA1 (0.42) | TRPA1ATMCYP2A6CYP1A2CYP3A4 | |
| SCHEMBL30022899 | 0.79 | CYP3A4 (0.43) | TRPA1ATMCYP2A6CYP1A2CYP3A4 | |
| SCHEMBL3778547 | 0.79 | TRPA1 (0.42) | TRPA1ATMCYP2A6CYP1A2CYP3A4 | |
| SCHEMBL1537728 | 0.79 | CYP3A4 (0.43) | TRPA1ATMCYP2A6CYP1A2CYP3A4 | |
| SCHEMBL1416730 | 0.77 | CYP3A4 (0.52) | TRPA1ATMCYP2A6CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2478981-B1 | SILVER-(CONJUGATED COMPOUND) COMPLEX | SUMITOMO CHEMICAL CO (JP) | 2020-12-23 | — | — | EP | disclosed |
| EP-2738220-B1 | COMPOSITION FOR POLYURETHANE FOAM, PREPARATION FOR POLYURETHANE FOAM, POLYMER POLYOL PREPARATION FOR POLYURETHANE FOAM, METHODS FOR PRODUCING THESE, AND POLYURETHANE FOAM | MITSUI CHEMICALS INC (JP) | 2018-09-19 | — | — | EP | disclosed |
| US-9704612-B2 | Composition of silver-conjugated compound composite | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-07-11 | — | — | US | disclosed |
| US-9412487-B2 | Silver-(conjugated compound) composite | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-08-09 | — | — | US | disclosed |
| US-20140155506-A1 | COMPOSITION FOR POLYURETHANE FOAM, PREPARATION FOR POLYURETHANE FOAM, POLYMER POLYOL PREPARATION FOR POLYURETHANE FOAM, PRODUCTION PROCESSES THEREFOR, AND POLYURETHANE FOAM | MITSUI CHEMICALS, INC. (JP) | 2014-06-05 | — | — | US | disclosed |
| EP-2738220-A1 | COMPOSITION FOR POLYURETHANE FOAM, PREPARATION FOR POLYURETHANE FOAM, POLYMER POLYOL PREPARATION FOR POLYURETHANE FOAM, METHODS FOR PRODUCING THESE, AND POLYURETHANE FOAM | Mitsui Chemicals, Inc. (JP) | 2014-06-04 | — | — | EP | disclosed |
| US-20140001422-A1 | COMPOSITION OF SILVER-CONJUGATED COMPOUND COMPOSITE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-01-02 | — | — | US | disclosed |
| EP-2478981-A1 | SILVER-(CONJUGATED COMPOUND) COMPLEX | Sumitomo Chemical Co., Ltd (JP) | 2012-07-25 | — | — | EP | disclosed |
| US-20120168693-A1 | SILVER-(CONJUGATED COMPOUND) COMPOSITE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-07-05 | — | — | US | disclosed |
| US-8129467-B2 | Curing accelerating compound-silica composite material, method for producing curing accelerating compound-silica composite material, curing accelerator, curable resin composition, and electronic component device | HITACHI CHEMICAL CO., LTD. (JP) | 2012-03-06 | — | — | US | disclosed |
| US-8013052-B2 | Curable resin, production method thereof, epoxy resin composition, and electronic device | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2011-09-06 | — | — | US | disclosed |
| US-20090062460-A1 | CURING ACCELERATING COMPOUND-SILICA COMPOSITE MATERIAL, METHOD FOR PRODUCING CURING ACCELERATING COMPOUND-SILICA COMPOSITE MATERIAL, CURING ACCELERATOR, CURABLE RESIN COMPOSITION, AND ELECTRONIC COMPONENT DEVICE | HITACHI CHEMICAL CO., LTD. (JP) | 2009-03-05 | — | — | US | disclosed |
| US-20090023855-A1 | NOVEL CURABLE RESIN, PRODUCTION METHOD THEREOF, EPOXY RESIN COMPOSITION, AND ELECTRONIC DEVICE | RESONAC CORPORATION (JP) | 2009-01-22 | — | — | US | disclosed |
| EP-1041100-B1 | PROCESSES FOR PRODUCING POLYOXYALKYLENE POLYOL AND PRODUCING DERIVATIVE THEREOF | MITSUI CHEMICALS INC (JP) | 2006-01-18 | — | — | EP | disclosed |
| US-6410676-B1 | USING PHOSPHAZENIUM CATALYST | MITSUI CHEMICALS, INC. (JP) | 2002-06-25 | — | — | US | disclosed |
| EP-1041100-A1 | PROCESSES FOR PRODUCING POLYOXYALKYLENE POLYOL AND PRODUCING DERIVATIVE THEREOF | Mitsui Chemicals, Inc. (JP) | 2000-10-04 | — | — | EP | disclosed |
| US-6022945-A | CATALYST IS COMPOSED OF A PHOSPHAZENE COMPOUND OR A PHOSPHAZENIUM SALT | MITSUI CHEMICALS, INC. (JP) | 2000-02-08 | — | — | US | disclosed |
| US-5952457-A | CATALYST COMPOSED OF PHOSPHAZENE COMPOUND OR PHOSPHAZENIUM SALT WHICH IS DERIVED FROM THE PHOSPHAZENE COMPOUND AND AN ACTIVE HYDROGEN COMPOUND | MITSUI CHEMICALS, INC. (JP) | 1999-09-14 | — | — | US | disclosed |
| EP-0763555-A2 | Alkylene oxide polymerisation catalysts | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1997-03-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062460-A1 | CURING ACCELERATING COMPOUND-SILICA COMPOSITE MATERIAL, METHOD FOR PRODUCING CURING ACCELERATING COMPOUND-SILICA COMPOSITE MATERIAL, CURING ACCELERATOR, CURABLE RESIN COMPOSITION, AND ELECTRONIC COMPONENT DEVICE | NCAPH, RAD51, H1-2 | TRPA1 1381/4885ATM 2963/4885CYP2A6 3893/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.